SCHEMBL20291998

SCHEMBL20291998

CNC(=O)N1CCC[C@@H]1C1CCN(C2CC3(CCN(C(=O)O)C3)C2)CC1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HRH3 Q9Y5N1 8/20 0.35
▸ CHRM4 P08173 4/20 0.35
▸ CHRM1 P11229 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ CYP3A4 P08684 1/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ ALOX15 P16050 1/20 0.31
▸ CHRM2 P08172 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20292045 1.00 NPC1 (0.39) NPC1RAB9ASMN1; SMN2HRH3CHRM4
SCHEMBL20292006 1.00 NPC1 (0.39) NPC1RAB9ASMN1; SMN2HRH3CHRM4
SCHEMBL19253045 0.97 NPC1 (0.38) NPC1RAB9ASMN1; SMN2HRH3CHRM4
SCHEMBL23853843 0.92 NPC1 (0.41) NPC1RAB9ASMN1; SMN2HRH3CHRM4
SCHEMBL20291977 0.90 TSHR (0.40) NPC1RAB9ASMN1; SMN2ALDH1A1CYP3A4
SCHEMBL23849577 0.90 CHRM4 (0.40) NPC1RAB9ASMN1; SMN2HRH3CHRM4
SCHEMBL16992538 0.89 CYP1A2 (0.43) NPC1RAB9ASMN1; SMN2CHRM4ALDH1A1
SCHEMBL18923661 0.89 CYP1A2 (0.43) NPC1RAB9ASMN1; SMN2CHRM4ALDH1A1
SCHEMBL20291999 0.89 CHRM4 (0.37) NPC1RAB9ASMN1; SMN2HRH3CHRM4
SCHEMBL20291982 0.89 HRH3 (0.34) NPC1RAB9ASMN1; SMN2HRH3CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3102568-B1 BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 RECEPTOR AGONISTS. HEPTARES THERAPEUTICS LTD (GB) 2018-06-27 — — EP claimed
Send feedback